If not improving, contact your healthcare provider about potential dose adjustment or extended hold at current level
Diabetes Obes Metab 11(10):953965 Madsen K, Knudsen LB, Agersoe H, Nielsen PF, Thgersen H, Wilken M, Johansen NL (2007) Structure-activity and protraction relationship of long-acting glucagon- like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness
If you have any concerns about your kidney health or creatinine levels while taking semaglutide, discuss them with your healthcare provider
Addressing those here
These symptoms can overlap with and potentially worsen the gastrointestinal effects already associated with GLP-1 therapy, making it difficult to distinguish which agent is responsible for adverse effects
While this is relatively rare in the United States, people can still get it when traveling abroad or from someone who has travelled recently